Can People Ever Stop Taking Statins Without Suffering a Heart Attack?

Many healthcare professionals and patients think of statin-type cholesterol-lowering medications as powerful shields against heart disease. Most, however, do not understand the actual risk reduction. We have repeatedly shared with readers a famous Lipitor (atorvastatin) ad. It described a clinical trial in which the drug company described its results in high-risk heart patients after five years: “That means in a large clinical study, 3 percent of patients taking a sugar pill or placebo had a heart attack compared to 2 percent of patients taking Lipitor.” Now we want to describe what happens when older people stop taking statins. Do they suffer a scary increase in heart attacks?

Prescribing Statins Based on a Calculator

Almost everyone over the age of 65 is encouraged to take a statin these days. One famous cardiologist once suggested putting statins in salt-shakers. He was half kidding, but half serious. Here is an article I recently wrote on this very idea:

Statins for Almost Everyone: Put Statins in Salt-Shakers?
The new guideline promotes statins for almost everyone, but absolute benefits may be much smaller than most patients and doctors realize.

Embracing the Guidelines:

I just used the most recent PREVENT™ Online Calculator for a theoretical 60-year-old patient with a systolic blood pressure of 118, total cholesterol of 140, and no chronic health conditions. Because the calculator estimated his 10-year risk of cardiovascular disease at 7.5%, he would be considered at “intermediate” risk for atherosclerotic cardiovascular disease (ASCVD).

That would make him a candidate for “lipid-lowering therapy” or LLT. And that, almost inevitably, would lead to a statin-type cholesterol-lowering medication.

If our theoretical man were a long-distance runner, a vegetarian and a low-stress individual with a great retirement nest egg, it would not matter to the calculator. Hopefully the physician who uses the calculator would take those factors into consideration.

If there were no family history of heart disease, perhaps our hypothetical patient would not end up on a statin. But over 50 million Americans have been prescribed statins and most of them are taking such drugs for primary prevention.

Let’s be very clear. There is a huge difference between primary and secondary prevention of heart disease. In primary prevention the person does not have diagnosed ASCVD (atherosclerotic cardiovascular disease). In other words, no prior heart attack, no stents and no obvious heart symptoms such as angina.

Secondary prevention is for people who have diagnosed ASCVD. They may have already had a heart attack or a stroke. Their CAC (coronary artery calcium) score may be in the danger zone, indicating a lot of plaque clogging heart arteries. They may also have symptoms of angina pectoris or peripheral artery disease (PAD). There is little argument that such patients deserve aggressive treatment by a cardiologist.

What Happens if Older People Stop Taking Statins?

Can older people ever stop taking statins? Leave it to French investigators to try and answer this question. Research published in The Lancet Healthy Longevity (July, 2026) attempted to find out if people 75 years or older could stop taking statins without suffering life-threatening cardiovascular complications.

Here is what the authors found in their own words:

“Among participants aged 75 years or older without previous ASCVD, statin discontinuation was non-inferior to continuation in terms of the primary clinical endpoint of all-cause mortality at 3 years. We did not observe an excess of cardiovascular events in the statin discontinuation group. We also did not observe significantly fewer adverse events in the statin discontinuation group than in the statin continuation group, possibly because participants had received statins for years, thus excluding people with early adverse events following statin administration.”

Let me say for the umpteenth time that I hate it when researchers use the “non-inferior” phrase. It just makes regular folks wonder what the heck they are talking about.

In plain English, it means that there was no difference between the people who were randomly assigned to continue taking statins and the people who were told to stop taking statins. Stopping statins over three years did not lead to more deaths.

The authors go on to describe higher risk patients:

“Subgroup analyses, particularly among participants with diabetes (or those with other cardiovascular risk factors), also showed no significant effect of statin discontinuation on mortality or ASCVD outcomes, despite mortality rates being nearly three times higher for persons with diabetes than for those without diabetes.”

If Really Old People Stop Taking Statins, What Happens?

First, we must share that observational trials from Italy, Denmark and France demonstrated that people over 75 experienced “an approximately 30% higher risk of cardiovascular events among those who discontinued statins for primary prevention compared with those who continued treatment.”

That may seem contradictory. But these were not controlled clinical trials. The authors of the latest randomized trial point out that “indication bias might explain the findings of these observational studies, which were not replicated in our controlled trial.”

There is a world of difference between an observational study that looks back at the data and a controlled trial that randomizes patients to either statins or no statins. The French authors point out some statistics that American cardiologists may be uncomfortable with:

“…the association between cholesterol and cardiovascular events weakens with age, and reviews of large observational cohort studies have reported higher all-cause mortality at low total cholesterol and LDL cholesterol concentrations—particularly when total cholesterol was less than 213 mg/dL (5·5 mmol/L) in individuals older than 80 years.”

The authors point out that one-third of Americans over 80 years of age “are given statins for primary prevention.”

They conclude:

“Among patients aged 75 years and older receiving statins for primary prevention—including those on long-term treatment courses—discontinuing statins was non-inferior to continuing statins and did not improve quality of life.”

The researchers explain this by noting that these individuals had been taking statins without problems prior to this study. That suggests that people who experienced unpleasant side effects such as muscle pain, weakness or rhabdomyolysis would have stopped statins long before this trial began and therefore would not have been included.

Final Words:

First, and most important, no one should ever stop any medication without discussing it first with the prescriber! That is especially true for statins! This is a conversation that must always take place between the patient and the healthcare provider.

In this French study, older people who were assigned to stop taking statins for primary prevention did not experience “an excess of cardiovascular events.” They also did not die faster than the group who continued to take statins.

I know that this was a somewhat complicated study. And whenever you see the words “non-inferiority” it can easily get confusing. Hopefully, you now have a better understanding of what the French researchers tried to convey.

Please let us know if this was understandable by adding your two cents in the comment section below. If you click on the green box labeled “View Comments” you can share your thoughts. I would be grateful for your insights.